ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach